Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094554	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"cervix, uterine: 35.6;prostate: 22.4;skin 1: 13.9;tongue: 11.6;vagina: 17.1"	"Cell line enriched"	"Detected in single"	38	"RPMI-8226: 19.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.4	0.3	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	22.4	0.0	0.1	0.6	0.1	0.1	13.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	11.6	1.2	0.6	17.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 163.1;breast: 50.7;vagina: 65.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 47.8;NB-4: 9.2;RPMI-8226: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 163.1;plasmacytoid DC: 49.1"	"Group enriched"	"Detected in many"	33	"dendritic cells: 49.1;granulocytes: 163.1"									"HPA003539, CAB018374"	Uncertain									"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favourable (9.78e-4)"	"prognostic favourable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	14.9	1.2	7.8	7.7	7.8	12.1	50.7	5.0	10.1	9.7	4.6	1.5	1.5	2.4	13.8	1.5	2.8	4.2	5.6	9.2	11.1	2.4	5.4	1.5	15.9	12.3	8.5	3.9	7.6	2.6	0.6	3.7	9.3	10.9	4.4	3.1	1.5	5.6	1.5	5.7	6.8	5.4	6.1	7.6	5.3	4.2	1.5	7.9	1.5	7.0	1.5	6.4	6.8	65.4	0.7	49.1	163.1	3.2	1.1	0.0	0.7	0.1	3.9	1.5	0.5	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.3	0.6	0.5	2.7	0.0	3.8	0.0	0.0	0.0	47.8	1.6	0.2	0.7	0.1	0.0	0.3	6.6	0.0	0.0	0.0	0.0	3.1	0.1	2.5	0.0	0.6	0.2	9.2	1.2	0.2	0.5	1.7	19.5	0.0	0.5	0.2	0.1	0.2	0.1	1.1	0.5	7.3	0.1	0.2	0.6	0.2	0.1	5.2	1.4	0.4	4.3	1.1	0.0	163.1	0.4	6.7	0.0	2.4	0.0	0.2	0.0	0.0	1.1	0.7	0.0	0.0	0.3	1.1	3.2	49.1	0.0	0.7	7.8	7.8	5.0	10.1	11.1	2.4	8.5	3.9	10.9	7.9
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1"	"Group enriched"	"Detected in some"	132	"HaCaT: 64.1;hTCEpi: 24.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		59000	59000	"Nuclear speckles, Cytosol"		"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.1	37.7	0.1	0.0	0.0	0.1	3.1	0.1	70.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	10.9	0.1	0.2	5.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.0	0.1	107.2	54.2	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"prostate: 39.0;urinary bladder: 52.4;vagina: 25.9"	"Group enriched"	"Detected in some"	6	"MCF7: 45.9;RT4: 51.8"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0;T-reg: 1.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced									"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavourable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.2	0.2	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	3.8	0.0	39.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	6.8	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	1.3	52.4	25.9	0.7	0.6	0.0	0.1	2.0	1.9	0.2	1.2	0.1	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.6	1.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 43.5;hTCEpi: 32.4;RT4: 50.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria				Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.3	43.5	0.0	0.2	0.0	8.6	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.4	0.5	6.0	0.0	0.0	3.2	0.0	0.4	0.3	0.0	0.1	4.3	0.0	0.0	2.4	0.0	50.5	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.2	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2
HBQ1	HBQ	ENSG00000086506	"Hemoglobin subunit theta 1"	P09105	16	180453-181181	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7"	"Group enriched"	"Detected in some"	7	"HEL: 13.1;Hep G2: 9.1;K-562: 32.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;T-cells: 2.3"					"Low region specificity"	"Detected in all"			HPA062473	Enhanced		Approved	"Lipid droplets"		47000	47000	"Lipid droplets"		"HPA062473: AB_2684774"		"unprognostic (4.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.02e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.55e-1)"	0.5	0.6	12.2	0.5	10.0	29.4	0.5	0.6	6.3	0.5	0.5	0.2	0.0	0.6	0.5	0.5	0.5	0.5	0.5	0.9	5.6	4.0	0.5	0.5	2.1	0.5	2.2	3.7	0.6	0.5	0.5	0.5	2.6	2.4	0.6	0.5	0.0	0.8	0.5	0.9	0.5	0.5	0.5	0.7	2.8	0.5	1.3	0.3	0.0	0.5	0.0	0.5	0.6	10.7	0.4	0.2	2.5	0.0	0.0	2.3	8.0	0.0	0.7	0.2	2.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	2.2	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	13.1	0.5	9.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	32.4	0.0	0.0	0.1	1.4	0.0	1.8	0.1	0.1	0.0	0.2	0.4	0.0	0.3	1.8	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	2.3	0.4	0.7	1.6	0.1	0.0	0.5	1.2	2.5	0.0	0.0	0.2	0.0	8.0	12.2	10.0	0.6	6.3	5.6	4.0	2.2	3.7	2.4	0.3
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815464-31817946	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"breast: 216.1;vagina: 741.6"	"Cell line enriched"	"Detected in some"	10	"HEK 293: 302.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 8.8;monocytes: 4.7;T-cells: 4.5"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		77000000	77000000	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	29.1	74.5	35.3	18.4	48.0	3.5	216.1	40.4	36.0	8.8	22.6	27.4	41.1	3.6	33.1	32.3	36.7	14.5	14.6	40.3	37.5	28.8	35.3	49.5	54.7	14.1	89.2	10.8	15.1	31.2	3.5	23.8	22.1	67.4	47.8	11.4	6.1	28.3	52.7	66.7	57.9	17.3	36.4	47.0	35.6	19.3	10.9	85.9	1.3	26.8	16.3	11.8	41.3	741.6	1.0	0.5	8.8	4.7	1.2	4.5	0.5	0.0	30.5	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.7	0.0	0.0	2.3	0.0	0.2	302.8	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.4	4.5	1.8	4.7	1.0	1.0	2.5	2.3	0.5	0.4	1.2	1.1	8.8	1.2	2.5	0.5	4.5	0.5	35.3	48.0	40.4	36.0	37.5	28.8	89.2	10.8	67.4	85.9
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815065	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"testis: 29.1;vagina: 17.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.7;U-266/70: 2.8;U-266/84: 2.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		49000000	49000000	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: "	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favourable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	0.4	0.5	1.8	0.5	2.2	0.5	1.2	1.4	3.1	0.5	0.7	1.5	0.0	0.3	0.8	3.0	0.8	1.5	0.3	0.5	2.0	1.1	0.9	0.7	1.7	0.7	4.5	0.8	1.1	1.5	0.3	0.7	1.0	2.6	1.2	0.6	0.2	0.4	1.5	3.9	0.6	0.8	0.5	4.6	1.1	0.8	29.1	3.2	0.0	2.0	0.0	0.7	0.5	17.0	0.3	0.0	0.4	0.1	0.0	1.7	1.1	0.0	1.7	0.0	0.0	1.9	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.9	0.0	0.0	6.7	0.0	0.0	0.2	0.2	1.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	2.8	2.4	0.0	1.7	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	1.0	1.3	0.0	0.3	1.5	1.6	0.3	0.0	0.0	0.0	1.7	1.1	1.8	2.2	1.4	3.1	2.0	1.1	4.5	0.8	2.6	3.2
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134974-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"vagina: 286.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		820000	820000	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.90e-4)"	"prognostic unfavourable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	13.7	19.8	36.6	12.2	57.1	9.8	33.7	11.7	44.0	14.7	10.6	9.8	13.0	6.1	13.3	21.7	13.9	31.0	18.1	14.2	34.8	40.3	16.6	14.8	15.9	17.4	36.5	16.3	13.4	10.1	15.1	24.1	19.8	32.7	14.5	14.5	3.6	7.0	17.3	10.5	11.0	6.4	15.7	34.8	9.0	12.2	35.0	34.6	12.1	22.5	7.8	23.8	17.0	286.1	9.0	6.8	2.1	14.6	13.7	12.8	5.5	14.5	27.8	23.0	2.2	22.1	12.6	15.3	25.2	22.4	39.2	18.3	32.7	22.6	37.7	15.8	17.5	28.2	88.5	22.4	50.6	29.5	11.1	32.7	15.4	28.8	7.3	22.6	26.1	7.9	51.8	26.1	15.0	22.6	27.3	6.0	27.4	19.8	32.4	25.9	32.7	20.8	25.6	18.8	12.5	29.5	17.7	23.8	19.8	22.9	22.6	11.6	7.5	22.0	13.7	13.5	17.2	19.4	27.8	4.7	15.4	32.3	11.2	27.5	22.5	1.0	3.9	2.1	6.6	9.6	8.1	9.0	8.4	10.0	6.8	7.8	12.8	11.9	0.4	13.7	14.6	5.3	5.3	5.5	36.6	57.1	11.7	44.0	34.8	40.3	36.5	16.3	32.7	34.6
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513743-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6"	"Group enriched"	"Detected in some"	10	"HaCaT: 120.2;hTCEpi: 92.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		580000000	580000000	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favourable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	0.6	0.0	1.4	0.6	1.5	0.0	37.4	0.6	1.1	14.6	1.1	0.6	0.6	0.0	0.6	0.6	115.3	2.7	10.6	0.6	1.3	0.0	1.1	0.6	2.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	3.0	1.1	16.4	0.0	1.4	15.1	0.6	0.6	119.3	3.5	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	1.9	6.2	0.8	38.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.6	2.1	0.0	0.2	0.0	120.2	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	92.9	0.2	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	10.2	0.3	0.7	0.2	0.0	0.1	1.7	0.1	2.3	0.0	2.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.5	0.6	1.1	1.3	0.0	0.6	0.6	1.1	0.6
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 59.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033311, HPA068414"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB033311: AB_781574, HPA068414: "	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	7.7	0.0	1.9	0.0	59.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	7.3	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165564-30166756	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0"	"Group enriched"	"Detected in some"	15	"HaCaT: 2.2;hTCEpi: 2.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced									"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	24.4	2.8	0.0	9.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390287	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7"	"Cell line enhanced"	"Detected in many"		"A549: 14.4;HEK 293: 20.7;MCF7: 9.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 25.1;naive B-cell: 27.5"	"Lineage enriched"	"Detected in many"	11	"B-cells: 27.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"				Microtubules	"Cytokinetic bridge"	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favourable (4.02e-5)"	"unprognostic (2.45e-1)"	0.4	0.3	0.2	0.2	0.8	0.2	2.5	0.2	0.2	58.9	0.5	0.2	0.2	0.2	4.4	1.4	268.7	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.3	0.2	39.0	0.3	0.5	37.3	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.9	0.2	323.6	276.3	0.2	85.7	27.5	2.4	0.5	2.0	0.0	0.7	1.0	4.6	14.4	0.3	1.3	0.7	0.7	0.2	0.8	0.3	0.3	0.3	0.8	1.2	4.0	6.5	0.2	1.9	1.2	1.8	0.1	0.0	20.7	0.3	5.4	1.5	0.0	0.0	0.0	1.5	3.2	0.8	0.0	0.0	0.8	0.2	0.0	9.8	0.0	0.1	5.3	4.3	1.7	0.2	2.2	1.4	1.8	2.2	6.3	2.7	4.0	1.9	4.9	2.0	0.0	0.0	4.4	0.1	0.0	4.7	5.6	2.6	0.0	1.7	0.2	0.0	2.0	0.0	0.7	1.5	0.2	25.1	0.5	0.5	2.4	27.5	0.2	0.4	0.5	0.0	0.3	0.5	0.0	1.0	0.2	0.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FAM167B	"C1orf90, MGC10820"	ENSG00000183615	"Family with sequence similarity 167 member B"	Q9BTA0	1	32247233-32248856	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"vagina: 91.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.9;EFO-21: 8.7;SK-MEL-30: 21.0;U-2197: 21.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 46.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029398, HPA062074"	Uncertain		Approved	"Actin filaments"				"Actin filaments"		"HPA029398: AB_10602807, HPA062074: "	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (6.03e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-3)"	"unprognostic (7.44e-3)"	"unprognostic (3.64e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.04e-2)"	"unprognostic (5.08e-2)"	17.2	10.5	1.4	5.0	1.7	0.1	20.1	1.7	1.9	6.1	3.1	1.1	7.4	3.6	7.8	2.2	4.5	3.4	5.5	11.3	1.8	1.7	20.3	18.4	22.4	6.2	3.2	0.6	3.8	6.6	5.2	8.5	5.8	3.3	9.2	2.7	5.2	2.6	8.2	3.3	1.1	4.1	7.5	2.6	1.4	4.0	1.8	2.7	1.2	11.8	1.5	1.9	7.2	91.1	1.0	0.0	0.8	0.0	0.3	4.5	0.7	0.6	1.2	0.4	0.0	0.9	0.8	0.0	3.0	6.9	1.3	1.9	0.0	0.6	0.1	8.7	5.1	1.0	0.2	0.0	0.4	0.1	0.0	0.0	2.7	0.4	0.3	0.0	0.1	0.8	0.5	1.0	0.3	2.5	0.0	0.0	0.1	0.4	0.1	0.0	0.2	2.9	0.6	0.0	0.8	0.8	0.3	1.3	0.3	1.9	0.1	21.0	0.3	0.0	2.2	0.6	0.7	21.5	0.0	0.1	0.2	0.4	0.2	0.1	0.2	0.0	0.0	0.8	2.6	0.0	0.7	0.5	0.8	0.8	0.0	1.0	0.5	1.6	0.0	0.3	0.0	0.0	4.5	0.7	1.4	1.7	1.7	1.9	1.8	1.7	3.2	0.6	3.3	2.7
FBXO47		ENSG00000204952	"F-box protein 47"	Q5MNV8	17	38936432-38967402	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"testis: 12.2;vagina: 3.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;Daudi: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA057438	Uncertain									"HPA057438: AB_2683441"		"unprognostic (1.53e-1)"			"unprognostic (2.98e-1)"			"unprognostic (2.82e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.59e-2)"		"unprognostic (2.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.15e-1)"			0.1	0.1	0.1	0.0	0.5	0.0	1.9	0.7	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.3	0.1	0.1	0.0	0.4	0.1	1.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	12.2	0.7	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.4	0.0	0.1	0.1	0.0	1.2	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.7	0.4	0.1	0.1	1.0	0.3	1.2	0.7
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Approved		Enhanced	Nucleoplasm,Cytosol		110000	110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.12e-5)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.5	34.6	10.0	16.8	12.5	7.4	48.1	15.3	5.5	25.3	17.2	34.4	19.0	20.8	4.4	9.8	21.3	62.3	20.7	30.5	38.0	39.9	22.9	25.5	12.2	9.6	17.9	6.2	6.7	19.0	29.9	30.0	14.7	21.0	29.7	10.1	44.7	31.3	16.2	85.5	25.0	18.8	17.6	12.4	21.3	19.9	14.5	20.8	17.7	48.4	7.7	65.3	12.1	7.8	12.5	39.3	14.0	38.5	7.4	11.3	30.7	11.1	26.7	12.7	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 459.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		7200000000	7200000000	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavourable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.7	0.0	111.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HaCaT: 8.9;SiHa: 5.5;U-2197: 11.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		11000000	11000000	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavourable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.1	8.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644298	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 32.5;esophagus: 48.4;tongue: 18.4;vagina: 41.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;HSkMC: 2.0;SiHa: 3.1;U-2197: 10.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048341, HPA049988, HPA055992"	Supported					5700000	5700000			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: "		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	32.5	0.1	0.1	0.1	0.0	1.8	0.1	48.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	7.0	0.1	0.3	4.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.1	18.4	2.3	8.7	41.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TMPRSS11D		ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884032	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052834	Uncertain				"Intracellular and membrane"					"HPA052834: AB_2681969"	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	67.6	20.3	0.4	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AADACL4		ENSG00000204518	"Arylacetamide deacetylase like 4"	Q5VUY2	1	12644547-12667086	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.8;epididymis: 3.5;vagina: 3.3"	"Cell line enhanced"	"Detected in single"		"REH: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																	"unprognostic (3.20e-1)"								"unprognostic (1.89e-2)"						2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8			0.0	0.4	3.5	0.0	0.7	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.7	0.0		0.1	0.2	0.0	0.0	0.7		1.1	0.0		0.0	1.4	0.2	0.0	0.0	0.5	0.0	0.6	0.4	1.4			0.0		0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC005324.3		ENSG00000251537			17	15571491-15651653	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"esophagus: 23.3;tongue: 21.1;vagina: 17.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.5;HeLa: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: "	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	7.5	2.8	0.9	1.5	1.0	1.0	7.7	0.9	1.0	5.3	2.2	1.3	0.0	2.1	0.7	1.5	23.3	0.8	4.0	2.6	0.8	0.9	0.9	1.0	2.1	1.6	3.7	0.0	0.7	1.0	0.8	0.7	12.4	2.7	1.4	0.9	0.2	2.4	1.1	2.9	4.4	1.6	2.1	1.5	1.0	2.8	1.8	1.0	1.6	1.8	21.1	17.5	3.2	17.9	0.6	0.6	0.0	0.1	0.0	0.5	0.0	0.6	3.5	0.1	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	3.1	0.1	0.1	1.0	6.5	0.0	0.0	0.1	1.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.9	1.0	0.8	0.9	3.7	0.0	2.7	1.0
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409059-19452020	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6"	"Group enriched"	"Detected in many"	7	"BEWO: 16.4;RT4: 40.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	17.4	1.7	3.1	0.7	5.9	0.4	20.7	2.3	6.8	1.4	3.5	0.9	5.3	3.0	1.3	3.0	1.8	2.8	1.3	3.2	3.0	1.9	1.6	2.6	1.5	0.6	4.4	0.3	1.3	4.7	2.7	1.6	20.0	4.5	9.4	3.1	1.4	1.8	6.8	2.1	4.0	1.7	2.1	2.9	1.2	41.0	1.3	4.7	0.4	1.8	1.0	0.8	31.3	40.6	1.0	1.2	0.0	3.1	0.0	1.0	0.5	0.6	1.2	2.0	1.1	3.5	0.2	16.4	1.0	0.7	0.4	0.5	0.3	1.0	0.7	0.4	0.1	2.4	0.5	3.2	0.9	1.3	0.6	1.1	0.9	1.5	0.7	0.2	1.0	1.1	3.0	1.2	1.4	3.4	1.7	2.0	1.1	0.9	1.9	0.9	1.5	0.5	1.6	0.6	0.4	0.3	40.2	3.8	0.9	0.2	1.0	0.2	1.4	1.4	1.7	0.3	0.8	0.3	0.5	0.7	0.9	0.8	0.3	0.8	0.7	0.0	0.1	0.0	0.8	3.1	0.2	1.0	0.3	0.3	0.3	0.4	1.0	0.2	0.0	0.0	0.0	1.2	0.3	0.5	3.1	5.9	2.3	6.8	3.0	1.9	4.4	0.3	4.5	4.7
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 7.6"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;U-937: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044500	Uncertain									"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.4	0.5	0.4	1.1	0.9	1.4	0.5	2.1	1.2	1.0	1.2	0.1	0.1	2.0	0.8	0.1	0.8	0.5	0.5	1.3	3.3	0.3	3.4	0.7	2.6	1.8	0.3	0.1	0.8	3.2	0.0	0.8	0.7	1.5	0.6	0.4	0.1	2.7	2.6	0.4	0.8	0.7	0.1	1.5	1.4	0.8	2.8	0.7	2.0	0.9	0.1	0.5	0.7	7.6	1.3	0.0	2.0	0.8	0.5	1.5	0.0	0.5	0.2	0.4	1.4	0.1	0.3	2.1	0.2	0.2	0.0	0.3	0.7	0.0	2.4	1.6	0.2	0.9	0.0	0.0	0.0	0.5	0.5	1.0	1.6	0.2	0.0	0.8	1.0	0.3	0.0	0.1	0.0	0.6	0.1	1.0	0.1	0.1	3.9	1.1	2.7	0.0	2.3	2.2	1.0	0.2	3.1	1.9	0.9	0.0	1.0	0.0	0.1	0.2	0.4	0.1	0.5	0.9	0.3	1.8	1.4	2.7	0.1	3.5	0.4	0.0	0.0	2.0	1.1	0.8	0.8	1.3	0.5	0.6	0.0	0.3	0.7	1.5	0.1	0.5	0.3	0.0	1.5	0.0	0.4	0.9	2.1	1.2	3.3	0.3	0.3	0.1	1.5	0.7
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.0;BJ: 46.1;BJ hTERT+: 30.4;fHDF/TERT166: 49.4;WM-115: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	2300000	2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: , HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	35.0	12.4	0.2	46.1	30.4	5.2	1.1	0.0	0.0	1.2	5.1	49.4	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	2.3	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	16.6	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.2	0.1	3.3	8.1	0.0	21.4	0.1	0.0	0.2	0.2	24.3	0.1	0.0	28.3	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469474	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol		28000	28000	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	23.7	39.3	37.8	26.9	44.4	20.7	58.9	33.1	52.1	25.7	27.9	22.6	28.9	21.0	31.7	34.9	27.2	56.4	18.6	47.8	38.2	38.2	31.5	28.4	21.9	29.4	61.8	29.7	30.3	25.4	32.0	37.0	34.9	50.1	32.0	34.9	11.5	24.7	35.3	48.5	20.8	20.7	40.0	42.5	21.5	22.8	40.5	54.3	26.0	37.6	24.5	40.3	24.8	177.1	44.3	36.6	34.5	45.1	42.3	42.3	26.9	33.4	66.2	18.1	23.7	28.1	20.3	31.9	25.0	19.8	39.3	29.5	49.6	29.0	62.4	19.6	24.4	38.4	65.4	32.0	43.8	24.8	38.9	29.4	33.0	59.8	20.8	18.6	42.5	17.9	42.8	26.4	12.9	37.0	36.3	20.1	24.5	92.1	45.6	35.3	31.5	69.8	36.8	21.5	31.1	30.9	34.9	28.0	30.8	23.1	51.8	21.4	31.6	25.6	19.2	21.3	30.3	23.8	35.5	20.3	40.8	47.9	30.9	37.2	23.4	32.6	28.2	34.5	37.8	39.0	42.3	44.3	34.8	38.7	36.6	34.3	40.0	40.1	20.2	42.3	45.1	34.1	40.0	26.9	37.8	44.4	33.1	52.1	38.2	38.2	61.8	29.7	50.1	54.3
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	5	"A-431: 17.1;HEL: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Cytosol"		5800000	5800000	Cytosol	"Nuclear speckles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.1	2.9	1.3	1.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	2.5	0.6	0.8	0.6	0.0	2.2	0.0	0.1	0.0	1.8	2.2	27.4	3.8	1.8	0.1	0.2	4.5	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.2	0.3	0.6	0.9	0.6	0.9	0.5	0.4	0.0	2.2	0.1	0.6	0.5	0.5	0.2	1.0	0.7	3.2	1.5	0.8	1.4	0.7	0.5	0.2	0.5	0.8	2.0	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3
BAG3		ENSG00000151929	"BCL2 associated athanogene 3"	O95817	10	119651370-119677819	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 115.2;vagina: 160.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		890000	890000	"Plasma membrane, Cytosol"		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	17.8	14.1	18.8	7.7	25.7	2.7	38.3	18.4	20.7	11.7	14.1	7.3	6.5	6.3	10.1	10.6	23.3	8.7	17.0	38.2	20.6	14.3	16.8	10.1	14.3	5.9	20.9	4.5	7.3	9.3	27.6	8.8	16.5	27.4	14.4	6.7	5.5	14.6	12.9	115.2	18.5	5.6	20.4	35.8	4.4	15.1	8.1	20.6	1.3	11.1	32.7	12.8	14.0	160.1	0.3	0.8	0.4	1.1	0.2	7.6	1.0	26.1	29.8	8.3	10.8	21.6	15.2	15.6	23.9	20.3	18.3	15.8	12.6	12.8	1.0	11.4	20.5	39.1	8.5	42.2	12.7	12.8	14.0	1.4	8.0	15.7	18.3	0.0	6.1	15.3	24.4	13.3	21.1	20.4	11.2	6.5	18.2	37.4	1.4	5.8	3.2	34.1	0.0	11.8	4.5	13.8	5.9	1.5	1.4	9.5	16.9	12.4	10.5	3.5	25.4	9.7	8.4	13.1	34.1	6.0	3.5	0.6	18.1	0.4	7.3	0.0	1.0	0.0	1.2	1.1	2.0	0.3	4.4	1.5	0.8	0.0	7.6	2.7	0.4	0.2	0.5	0.2	3.0	1.0	18.8	25.7	18.4	20.7	20.6	14.3	20.9	4.5	27.4	20.6
C17orf67		ENSG00000214226	"Chromosome 17 open reading frame 67"	Q0P5P2	17	56791913-56838773	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"vagina: 24.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.8;MOLT-4: 15.0;PC-3: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 3.8"	"Low region specificity"	"Detected in many"			HPA043479	Uncertain				"Secreted - unknown location"					"HPA043479: AB_10964083"	"unprognostic (2.78e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.64e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.68e-5)"	"unprognostic (2.49e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-3)"	3.2	1.9	5.5	3.4	7.3	1.0	7.4	9.9	6.2	5.1	2.2	2.0	3.5	1.9	5.2	4.0	2.4	3.3	4.8	2.2	5.2	2.9	2.1	3.3	3.1	3.9	6.4	1.6	4.4	3.3	2.1	3.2	2.2	5.8	4.9	1.4	1.3	2.8	3.5	1.7	2.0	2.7	4.8	3.6	6.9	2.8	3.8	8.5	9.1	2.4	0.5	2.7	5.2	24.4	3.8	1.1	0.9	0.8	0.6	3.9	1.0	3.3	2.1	1.4	1.5	0.7	1.0	0.6	1.9	2.5	1.6	2.0	2.7	1.1	1.7	3.4	0.8	1.6	0.9	0.5	1.6	9.8	3.6	1.7	2.3	1.6	0.8	1.3	3.3	0.4	2.7	1.1	1.1	1.6	1.6	8.5	1.1	2.5	15.0	2.3	1.3	10.4	3.2	2.7	1.8	1.2	0.9	0.7	1.8	1.9	0.4	1.0	2.1	0.9	2.3	1.8	4.4	1.2	1.4	3.5	8.8	1.0	1.2	1.5	0.6	0.0	0.5	0.9	0.6	0.7	1.2	3.8	1.9	2.6	0.4	2.3	2.0	2.5	0.8	0.6	0.8	1.1	3.9	1.0	5.5	7.3	9.9	6.2	5.2	2.9	6.4	1.6	5.8	8.5
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Approved		Enhanced	Nucleoplasm,Cytosol		360000	360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: "	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favourable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.4	21.1	31.1	13.3	10.4	11.7	20.0	23.4	13.9	30.4	22.2	21.7	19.1	32.2	24.5	16.6	16.7	38.7	17.1	31.5	17.0	23.6	24.1	20.8	23.3	7.9	32.4	15.1	7.8	10.6	24.9	15.1	21.3	48.3	18.1	21.8	11.3	49.8	29.6	29.5	9.8	22.5	22.1	37.1	21.6	24.4	21.4	20.6	15.9	27.9	24.1	21.6	28.4	11.0	17.3	18.5	24.1	37.5	17.5	50.2	71.4	14.5	28.5	20.1	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524009-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 108.7;skin 1: 40.8;vagina: 42.4"	"Group enriched"	"Detected in some"	6	"A-431: 16.5;hTCEpi: 6.5;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	15	"cervical cancer: 150.9;head and neck cancer: 196.3;lung cancer: 59.9;melanoma: 47.8;urothelial cancer: 43.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					500000	500000			"CAB010070: , HPA044999: "	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	24.5	0.0			0.0	0.0	0.0	108.7	0.2	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		29.8	0.0	0.1	40.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		9.0	0.0	42.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CD177	"HNA2A, NB1, PRV1"	ENSG00000204936	"CD177 molecule"		19	43353659-43363172	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 67.6;intestine: 43.5;lymphoid tissue: 33.9;vagina: 30.8"	"Cell line enriched"	"Detected in some"	24	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.6"					"Cell type enriched"	"Detected in some"	7	"neutrophil: 11.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 11.3"									"HPA041820, HPA046601"	Enhanced				"Intracellular and membrane"					"HPA041820: AB_2677691, HPA046601: AB_2679716"	"unprognostic (4.32e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.24e-1)"	1.0	0.0	0.0	8.3	0.0	67.6	0.7	0.0	0.9	2.3	39.5	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	17.3	0.0		0.0	2.1	16.6	26.6	0.1	0.0	2.0	1.0	0.0	0.0	0.4	1.9	17.3	43.5	0.9	0.0	0.0	0.0	0.0	0.0	0.6	4.8	33.9	0.0	1.1	0.0	2.0	1.3	7.2	2.3	0.8	30.8	0.0	0.0	11.3	1.6	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.3	0.3	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	44.9	0.7	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	1.6	0.0	0.9	0.0										
CGAS	"C6orf150, cGAS, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452276	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 32.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 21.2;RPMI-8226: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite"	Cytosol	"HPA031700: AB_10601693, HPA031702: "	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	6.5	2.0	2.9	10.5	4.5	18.5	8.1	1.2	3.9	4.7	3.7	3.4	2.1	4.1	5.5	2.8	5.3	3.9	4.3	3.2	2.8	2.9	2.5	1.9	9.6	11.8	7.2	0.6	3.4	3.8	2.3	1.8	4.8	4.4	6.6	3.1	2.2	4.2	2.9	1.9	1.8	5.2	3.6	4.7	12.8	3.5	1.7	4.3	6.2	3.9	4.2	15.5	6.6	32.0	6.3	12.5	13.3	12.9	3.0	6.0	3.9	8.8	3.0	0.0	0.1	0.6	1.3	0.0	4.4	1.9	5.8	6.4	9.8	6.7	0.1	9.7	2.1	4.6	4.9	0.0	6.2	14.7	0.0	7.7	3.8	0.0	2.1	5.9	5.4	0.8	1.6	5.7	0.0	1.7	0.0	18.4	4.2	3.6	0.0	13.4	2.9	5.4	11.5	21.2	22.3	0.0	3.7	0.1	0.0	7.8	0.2	4.6	0.0	16.0	2.0	0.0	4.3	3.9	0.1	4.0	8.7	0.1	0.0	8.5	5.8	13.3	9.2	13.2	4.6	12.9	3.6	6.3	6.0	4.6	5.4	4.8	1.4	2.6	5.8	3.0	7.8	12.5	5.8	3.9	2.9	4.5	1.2	3.9	2.8	2.9	7.2	0.6	4.4	4.3
CHORDC1	"CHP-1, CHP1"	ENSG00000110172	"Cysteine and histidine rich domain containing 1"	Q9UHD1	11	90201160-90223364	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041040	Approved		Supported	Cytosol		51000	51000	Cytosol		"HPA041040: AB_10794185"	"unprognostic (2.29e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (4.93e-7)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (4.23e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-1)"	13.9	17.8	24.9	18.1	31.9	17.8	22.2	29.9	30.7	12.5	10.9	9.0	10.6	10.6	13.8	17.3	13.1	13.2	12.4	17.1	23.6	24.6	11.0	16.2	12.4	21.3	37.8	12.9	19.8	9.5	14.1	47.6	21.3	33.7	14.8	13.2	6.1	9.6	13.0	12.9	12.4	9.0	12.8	39.8	15.3	12.1	13.1	40.2	14.2	16.8	8.7	23.3	14.9	100.9	12.6	11.9	7.9	12.5	14.5	15.5	9.3	9.6	27.8	9.3	6.1	8.9	5.0	14.0	12.0	4.0	11.5	10.2	39.7	7.6	17.0	20.2	5.1	13.2	27.1	6.3	14.3	15.1	13.8	16.8	16.2	18.8	7.1	11.9	11.2	1.8	7.4	10.9	12.8	9.1	24.5	7.5	13.6	4.9	11.1	16.3	10.9	23.1	16.7	5.8	9.4	9.6	4.4	8.9	3.8	13.3	10.8	4.8	17.7	5.6	8.7	8.6	19.0	12.9	14.2	3.5	27.2	13.6	2.7	17.7	7.7	6.8	7.7	7.9	12.0	12.5	12.9	12.6	13.1	12.5	11.9	10.8	14.0	13.3	2.3	14.5	8.0	9.2	15.5	9.3	24.9	31.9	29.9	30.7	23.6	24.6	37.8	12.9	33.7	40.2
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 33.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Focal adhesion sites"	"Plasma membrane"	"HPA054381: AB_2682468"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.20e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.03e-5)"	"prognostic unfavourable (3.64e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.50e-11)"	"unprognostic (4.37e-1)"	"unprognostic (5.39e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	2.9	3.3	1.7	4.4	1.7	0.6	4.9	1.8	1.7	2.7	6.4	0.4	1.6	7.8	4.7	1.9	4.0	1.1	16.3	2.4	1.7	1.8	0.9	1.8	1.4	2.0	1.9	0.3	1.7	11.8	0.0	0.7	2.1	1.2	3.6	7.1	3.5	1.7	0.7	5.8	1.0	6.8	6.1	1.3	1.9	5.3	9.8	0.6	4.5	1.6	2.9	4.4	5.7	33.9	0.9	1.1	3.4	1.6	1.6	1.4	0.7	6.6	17.1	9.3	5.2	1.1	0.8	3.8	4.9	2.4	5.4	9.9	6.5	31.6	3.9	12.1	1.0	5.9	17.9	7.2	5.6	8.0	21.4	7.3	13.4	6.5	0.6	4.9	10.4	0.3	1.3	1.4	2.0	10.1	7.1	5.2	3.4	14.5	6.2	1.7	7.5	4.7	8.0	10.8	4.0	6.5	15.9	15.8	23.2	11.7	11.4	5.4	25.4	1.2	2.2	7.4	8.9	5.4	15.3	6.0	24.7	4.4	4.5	8.0	6.8	3.0	1.6	2.5	0.8	1.6	0.4	0.3	0.8	0.5	0.9	0.9	1.4	1.4	3.4	1.6	1.3	1.1	0.3	0.7	1.7	1.7	1.8	1.7	1.7	1.8	1.9	0.3	1.2	0.6
CLIC2	XAP121	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 62.3;vagina: 66.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 36.5;K-562: 19.7;Karpas-707: 18.2;RPMI-8226: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 24.5;monocytes: 9.5"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		290000	290000	"Plasma membrane"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	26.5	3.7	3.8	7.5	6.1	3.4	24.1	2.6	4.8	15.5	6.8	0.6	3.3	4.0	11.3	10.5	10.4	6.5	9.8	9.4	3.7	3.4	5.4	6.3	31.0	15.6	7.5	1.4	12.5	2.6	2.0	7.8	4.5	6.8	9.1	6.9	3.0	5.4	3.2	10.3	5.2	7.3	10.2	5.2	32.1	4.7	5.6	4.3	6.9	62.3	8.7	12.4	14.0	66.1	0.0	24.5	0.6	9.5	1.1	0.1	1.0	0.2	0.0	0.4	0.3	0.3	2.0	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	36.5	0.2	5.1	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	19.7	18.2	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	31.1	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.4	0.0	1.7	0.5	0.7	0.3	1.1	1.6	0.0	0.9	1.1	0.6	0.0	1.8	0.1	0.0	9.5	0.1	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.6	1.1	6.5	2.5	0.0	1.0	3.8	6.1	2.6	4.8	3.7	3.4	7.5	1.4	6.8	4.3
CRCT1	"C1orf42, NICE-1"	ENSG00000169509	"Cysteine rich C-terminal 1"	Q9UGL9	1	152514502-152516010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 212.8;lymphoid tissue: 82.6;tongue: 126.1;vagina: 69.4"	"Cell line enriched"	"Detected in single"	11	"CAPAN-2: 10.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 68.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.01e-2)"				"unprognostic (6.92e-2)"		"unprognostic (2.86e-2)"	"unprognostic (3.30e-1)"		"prognostic unfavourable (7.03e-4)"			"unprognostic (1.56e-2)"			"unprognostic (1.46e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	46.9	0.1	0.1	0.1	0.2	2.3	0.1	212.8	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	22.9	0.1	0.7	38.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	126.1	82.6	0.1	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DEDD2	FLAME-3	ENSG00000160570	"Death effector domain containing 2"	Q8WXF8	19	42198598-42220140	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 58.6"	"Cell line enhanced"	"Detected in many"		"A549: 22.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043419			Approved	Nucleoplasm				Nucleoplasm		"HPA043419: "	"unprognostic (1.59e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.70e-2)"	"prognostic favourable (3.26e-6)"	8.7	12.5	9.9	13.5	13.1	22.2	12.3	17.6	14.9	7.8	13.8	6.0	11.5	14.5	7.2	7.9	11.6	9.6	6.4	6.3	9.4	15.4	11.5	11.1	12.9	12.7	14.5	5.7	9.7	11.6	7.1	17.0	10.5	10.4	13.8	5.7	6.3	11.6	8.2	13.6	11.4	13.2	5.8	8.2	17.8	19.7	9.6	10.5	17.2	24.1	6.3	13.2	10.4	58.6	16.9	19.0	49.2	29.1	14.3	21.9	24.2	9.9	22.5	1.5	1.8	3.4	0.8	6.7	4.0	3.5	3.2	2.2	6.3	6.5	6.5	7.9	1.2	4.0	6.8	1.5	1.5	5.4	18.0	3.1	5.3	9.6	4.3	3.7	6.7	0.5	3.8	2.5	3.4	1.9	15.6	7.3	0.9	4.3	3.8	11.6	3.6	13.6	4.5	2.8	5.6	2.6	3.6	11.6	4.5	3.6	10.7	2.1	1.9	4.2	3.3	2.5	7.7	1.0	7.3	13.6	6.2	2.0	3.7	5.7	2.6	27.5	21.5	34.5	20.1	27.0	21.9	16.9	18.6	19.2	13.5	16.4	16.8	17.3	49.2	14.3	29.1	19.0	17.4	24.2	9.9	13.1	17.6	14.9	9.4	15.4	14.5	5.7	10.4	10.5
DEFB103A	"DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3"	ENSG00000176797	"Defensin beta 103A"	P81534	8	7881204-7882664	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.7;U-2 OS: 1.2;U-2197: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.3	0.0	0.1	0.1	0.1	0.0	1.0	0.1	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.5	3.3	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	16.7	6.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 48.8;RT4: 58.4;SK-BR-3: 285.8;U-2 OS: 93.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	19.7	1.5	0.1	0.0	48.8	0.0	0.2	1.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	2.2	0.1	0.4	0.1	0.0	58.4	0.2	0.3	0.4	285.8	0.3	0.2	0.0	0.0	0.1	93.6	0.5	0.2	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0
DNAJA1	"dj-2, hdj-2, HSJ2, HSPF4, NEDD7"	ENSG00000086061	"DnaJ heat shock protein family (Hsp40) member A1"	P31689	9	33025211-33039907	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 189.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001306	Approved		Supported	Microtubules,Cytosol				Cytosol	Microtubules	"HPA001306: AB_1079043"	"unprognostic (3.11e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.58e-2)"	"prognostic favourable (5.39e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (3.27e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.70e-2)"	29.0	46.7	46.5	26.1	47.2	42.7	57.2	31.6	53.3	30.4	18.7	20.7	25.5	14.4	27.6	27.9	17.1	34.8	28.2	22.2	42.5	51.7	36.0	71.9	30.7	23.8	56.5	30.8	30.7	19.5	47.3	40.2	35.0	49.6	29.8	21.7	9.0	18.9	23.0	14.5	13.1	15.9	29.0	42.4	22.3	20.8	42.2	51.5	24.1	47.0	15.3	28.1	27.9	189.5	36.6	60.0	50.0	69.0	31.6	37.2	49.5	38.0	68.3	55.3	19.2	38.5	25.0	31.7	39.4	31.8	70.9	55.2	45.3	17.7	39.1	30.2	26.7	17.4	79.6	23.7	61.2	55.0	23.2	31.3	84.1	57.3	18.5	36.0	36.8	15.4	24.4	26.7	8.5	42.2	48.7	17.1	40.5	31.1	60.0	79.2	53.8	47.7	44.2	19.8	20.0	39.7	22.6	35.2	38.4	53.0	34.3	17.5	16.0	35.0	36.1	25.3	43.3	28.8	52.2	11.0	34.0	41.3	33.2	31.4	21.7	33.3	40.1	43.3	28.5	56.0	33.3	36.6	35.6	31.4	35.7	32.7	37.2	34.7	50.0	31.6	69.0	60.0	30.1	49.5	46.5	47.2	31.6	53.3	42.5	51.7	56.5	30.8	49.6	51.5
DNAJB1	"Hsp40, HSPF1, RSPH16B, Sis1"	ENSG00000132002	"DnaJ heat shock protein family (Hsp40) member B1"	P25685	19	14514770-14529770	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 291.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 109.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017450, HPA063247"	Enhanced		Supported	Nucleoplasm		9600	9600	Nucleoplasm		"CAB017450: AB_10631418, HPA063247: "	"unprognostic (3.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.91e-3)"	"unprognostic (2.17e-1)"	"prognostic favourable (5.96e-4)"	"unprognostic (2.20e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.77e-2)"	29.2	76.9	28.5	13.2	30.0	36.2	67.0	41.4	29.4	19.3	15.5	21.5	14.5	10.5	20.4	11.8	72.3	21.7	56.4	23.5	28.2	31.6	23.4	37.7	35.7	10.7	53.4	12.0	32.3	22.6	18.3	25.0	33.5	45.8	29.6	13.1	12.2	18.4	40.8	16.1	25.3	9.5	24.0	40.2	9.4	19.1	37.5	37.9	15.0	28.9	18.0	31.1	19.2	291.1	19.7	15.2	28.2	31.6	23.0	61.6	56.7	36.6	39.0	14.1	15.0	26.0	20.9	8.8	24.4	18.1	38.7	29.3	23.0	20.7	10.1	28.0	20.8	27.9	28.8	17.5	27.4	10.6	14.3	16.1	25.8	48.2	17.7	11.4	15.3	11.6	42.1	14.9	13.1	12.7	23.9	109.8	21.3	23.2	18.3	10.6	15.0	42.0	14.0	19.9	22.8	17.6	12.6	13.0	9.6	22.1	43.8	24.0	12.0	11.1	13.2	31.4	18.9	36.2	51.2	48.9	30.0	13.3	22.4	19.8	28.0	11.5	18.9	22.3	36.6	31.1	38.9	19.4	52.5	45.4	15.2	19.7	61.6	47.6	28.2	23.0	31.6	9.1	51.8	56.7	28.5	30.0	41.4	29.4	28.2	31.6	53.4	12.0	45.8	37.9
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 89.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 42.5;LHCN-M2: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	23.3	39.0	19.2	8.4	20.7	4.9	16.6	22.7	24.1	21.3	12.7	7.2	9.3	5.4	20.8	10.1	25.0	11.7	25.2	42.0	18.0	16.8	16.0	15.5	21.7	7.0	25.7	9.1	15.3	18.5	16.4	19.1	19.5	23.8	19.4	9.4	5.1	7.0	12.2	33.3	7.6	8.8	23.0	29.5	30.3	11.9	7.8	22.5	2.8	35.1	29.4	5.1	22.1	89.8	3.6	5.0	4.5	1.9	3.1	7.2	2.6	1.4	2.7	3.5	2.0	15.0	28.0	1.6	27.2	6.9	12.1	13.7	0.9	1.8	2.0	4.6	12.9	2.1	4.4	2.4	20.7	2.3	1.2	1.0	8.2	6.6	20.3	0.5	0.5	11.6	6.6	15.7	4.5	42.5	4.4	1.4	72.3	0.1	0.6	1.5	2.1	1.3	1.1	6.0	1.3	2.9	0.7	2.5	0.8	3.1	2.3	2.6	0.9	0.8	20.3	17.1	4.2	12.1	3.5	1.2	0.4	1.8	2.3	1.2	2.9	4.5	1.7	2.7	2.6	1.7	4.4	3.6	3.2	3.1	1.7	3.0	7.2	5.1	0.4	3.1	1.9	5.0	4.2	2.6	19.2	20.7	22.7	24.1	18.0	16.8	25.7	9.1	23.8	22.5
EDN3	ET3	ENSG00000124205	"Endothelin 3"	P14138	20	59300427-59325992	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8;retina: 86.8;salivary gland: 37.0;vagina: 37.8"	"Cell line enriched"	"Detected in single"	5	"SH-SY5Y: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory CD4 T-cell: 2.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"												"Secreted to blood"						"unprognostic (4.64e-3)"	"unprognostic (7.87e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.73e-4)"	"unprognostic (1.58e-1)"		"unprognostic (1.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.08e-2)"	"unprognostic (4.48e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.40e-2)"		0.0	1.2	1.1	0.7	2.5	0.0	3.7	0.8	3.3	22.7	21.7	2.1	0.2	20.7	2.6	3.2	9.2	0.0	1.3	0.0	2.3	1.6	0.2	0.0	0.2	0.0	1.8	1.7	0.6	5.1	0.0	20.8	0.2	3.2	3.2	8.9	86.8	37.0	0.4	0.6	0.8	35.8	1.3	1.7	3.6	0.8	1.1	0.4	0.1	33.2	1.3	0.6	0.2	37.8	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	1.1	2.5	0.8	3.3	2.3	1.6	1.8	1.7	3.2	0.4
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 29.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	4.1	2.8	2.9	12.2	3.4	3.4	6.5	2.8	3.8	6.5	4.7	2.3	3.5	4.8	8.9	4.4	2.4	4.2	4.1	3.5	2.3	1.5	7.5	4.0	3.1	4.3	3.6	0.4	5.5	2.8	8.4	7.6	5.4	3.2	9.3	3.4	2.6	5.4	2.0	1.3	2.2	6.3	9.9	3.5	4.6	3.5	20.0	2.7	2.4	14.9	0.7	4.3	5.5	29.9	5.6	1.0	5.3	2.1	0.8	2.6	0.8	0.9	3.9	1.7	0.2	2.1	7.2	3.0	2.2	0.5	0.6	1.1	1.7	5.6	0.3	6.5	0.8	1.0	0.0	0.4	3.9	0.2	0.6	5.1	3.2	0.5	2.0	3.9	0.6	1.3	1.9	2.7	0.0	4.4	1.5	9.7	2.4	0.1	1.7	2.2	0.9	3.1	4.6	1.2	1.8	9.1	3.2	1.2	0.6	1.2	0.1	2.6	6.5	4.7	1.6	0.2	1.3	0.4	1.0	10.0	6.9	0.9	6.2	7.7	4.2	5.3	2.1	0.6	1.1	1.2	0.9	4.3	0.9	0.6	1.0	5.6	2.6	1.2	0.0	0.8	0.7	0.4	0.1	0.8	2.9	3.4	2.8	3.8	2.3	1.5	3.6	0.4	3.2	2.7
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074939-79088599	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 51.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Approved		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favourable (8.73e-5)"	10.0	10.1	9.5	20.7	18.4	8.9	11.4	7.0	13.9	10.9	15.1	12.4	8.8	20.3	11.4	6.8	6.5	10.6	8.6	10.3	9.3	5.8	9.2	10.2	10.1	10.7	16.8	8.5	16.3	9.3	11.3	9.8	8.1	13.6	12.3	12.5	10.7	12.1	9.6	35.4	11.9	17.3	7.3	11.9	24.9	11.4	3.9	14.0	8.1	13.6	7.0	9.1	17.5	51.4	0.2	0.7	0.0	1.1	0.0	2.1	0.6	4.5	9.6	3.4	6.2	3.6	1.5	6.5	3.4	1.7	2.8	2.0	5.1	4.9	0.0	4.2	3.5	6.7	5.4	3.7	1.6	2.7	7.2	4.0	9.8	3.0	2.7	4.6	7.7	4.0	5.2	2.4	2.7	2.9	5.8	2.8	1.8	3.8	0.4	4.4	1.5	8.7	8.5	11.6	2.9	1.5	12.7	2.8	5.7	5.5	25.5	2.5	9.0	4.4	3.8	5.5	4.1	4.8	3.4	6.8	1.2	1.9	2.3	8.5	4.0	0.0	0.7	0.0	0.0	1.1	0.9	0.0	0.1	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.6	2.1	0.6	9.5	18.4	7.0	13.9	9.3	5.8	16.8	8.5	13.6	14.0
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ovary: 19.1;testis: 30.2;vagina: 14.3"	"Cell line enhanced"	"Detected in some"		"U-266/70: 10.5;U-698: 17.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.8"	CAB079300	Enhanced									"CAB079300: "	"unprognostic (7.63e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.27e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.89e-2)"	2.1	9.4	0.2	2.3	0.8	1.0	3.7	0.8	0.6	1.3	2.9	0.6	0.2	1.4	1.7	0.7	1.7	1.1	0.6	1.0	1.1	0.4	1.4	0.7	1.3	2.8	0.2	0.2	19.1	2.5	0.0	1.6	0.7	1.4	2.2	1.5	0.5	1.5	0.9	1.4	1.2	1.5	0.6	1.0	3.0	1.3	30.2	0.6	5.0	0.6	0.2	2.9	1.8	14.3	2.4	4.0	1.1	0.3	0.4	1.3	0.2	0.7	0.3	0.7	0.6	0.0	0.1	1.3	0.1	0.0	0.1	0.1	0.2	0.8	2.8	0.1	0.0	1.0	0.9	0.0	0.1	0.7	0.3	0.3	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.6	4.0	0.1	0.7	0.4	0.2	0.7	0.4	0.5	0.3	0.2	0.1	1.3	2.4	0.7	0.5	0.2	1.1	0.8	0.0	0.4	0.5	0.9	0.2	0.1	10.5	3.2	17.2	0.2	0.1	0.7	0.3	0.3	1.0	0.8	0.2	0.6	1.7	0.6	1.1	0.1	2.4	1.3	1.0	1.1	0.4	0.2	4.0	0.5	0.2	0.2	0.8	0.8	0.6	1.1	0.4	0.2	0.2	1.4	0.6
EVX2		ENSG00000174279	"Even-skipped homeobox 2"	Q03828	2	176077472-176083913	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.4;prostate: 3.8;seminal vesicle: 5.0;testis: 6.1;vagina: 2.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;SCLC-21H: 1.5;SH-SY5Y: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.6;pons and medulla: 1.2"	"Region enriched"	"Detected in single"	7	"pons and medulla: 0.8"	HPA041576	Uncertain									"HPA041576: AB_10796347"		"unprognostic (2.27e-1)"	"unprognostic (1.68e-3)"		"unprognostic (1.83e-1)"				"unprognostic (3.41e-1)"	"unprognostic (5.75e-1)"		"unprognostic (3.13e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.32e-1)"		"unprognostic (4.93e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.9			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		3.8	1.8		0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1			0.0		0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 92.9;MOLT-4: 90.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	28000000	28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.7	16.5	10.1	0.0	48.4	4.5	0.0	11.8	0.6	9.2	11.7	0.1	7.9	92.9	6.8	2.9	5.4	24.6	18.9	7.9	47.2	53.4	33.5	11.8	25.0	4.3	32.0	8.7	3.5	38.9	11.4	23.5	53.0	9.6	10.1	5.5	5.6	90.8	16.4	13.4	64.3	40.5	0.0	9.8	14.8	71.8	42.0	15.9	5.7	1.9	4.4	0.0	16.5	7.5	0.0	26.3	0.1	0.1	12.5	4.9	66.2	4.2	30.7	14.8	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6
FAM25A	bA96C23.5	ENSG00000188100	"Family with sequence similarity 25 member A"	B3EWG3	10	87020306-87024730	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.5;skin 1: 30.9;tongue: 61.1;vagina: 30.8"	"Group enriched"	"Detected in some"	6	"A-431: 13.3;SK-BR-3: 39.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 53.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-1)"				"unprognostic (7.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.05e-5)"						"unprognostic (1.21e-1)"	0.2	0.1	0.2	0.2	0.2	0.0	1.9	0.2	0.2	21.6	0.2	0.2	0.2	0.0	1.1	0.2	85.5	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.0	0.2	19.9	0.2	0.3	30.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	61.1	16.9	0.2	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	39.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 154.6;ASC TERT1: 68.6;BJ: 82.9;BJ hTERT+: 131.8;HSkMC: 113.1;RT4: 118.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	34000000000	34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.3	3.3	10.0	21.0	154.6	68.6	46.0	82.9	131.8	7.4	2.8	14.2	0.4	0.0	3.5	3.0	7.3	6.3	0.2	0.9	0.0	1.7	0.0	18.1	9.5	20.5	0.0	0.0	113.1	1.3	7.3	2.7	0.0	0.0	0.1	5.1	0.1	0.0	0.2	14.1	1.2	0.1	0.0	0.1	3.3	118.6	0.7	13.4	10.2	48.3	0.0	0.3	0.4	0.6	1.4	9.2	38.1	0.0	0.1	0.0	0.1	0.1	0.0	3.5	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312440-1314748	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 65.5;vagina: 39.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.4;CAPAN-2: 9.9;HaCaT: 19.2;Hep G2: 40.4;RT4: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059700			Supported	Nucleoplasm				Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favourable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.6	0.5	2.3	0.6	4.0	0.5	1.4	1.6	5.9	7.1	1.9	3.2	0.0	6.9	1.1	0.7	7.2	3.2	31.8	0.5	2.2	1.9	7.1	3.6	5.8	0.5	2.7	1.5	0.5	10.1	0.5	1.8	1.2	3.8	18.2	0.8	7.5	35.8	1.3	0.6	16.8	0.8	6.6	1.9	0.5	65.5	0.6	0.8	0.8	3.1	7.8	11.7	26.3	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.5	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.0	0.0	16.4	9.9	0.0	0.2	0.0	19.2	0.0	0.8	0.0	0.0	0.5	0.0	3.5	40.4	0.0	0.0	1.0	0.0	7.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	17.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	4.0	1.6	5.9	2.2	1.9	2.7	1.5	3.8	0.8
GABRE		ENSG00000102287	"Gamma-aminobutyric acid type A receptor epsilon subunit"	P78334	X	151953124-151974680	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"placenta: 36.4;vagina: 27.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.3;EFO-21: 14.6;HeLa: 6.5;SiHa: 6.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"hypothalamus: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA045918	Uncertain									"HPA045918: AB_10961281"	"unprognostic (1.33e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.39e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (6.73e-2)"	"prognostic unfavourable (4.05e-11)"	"unprognostic (1.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.28e-2)"	14.8	1.0	1.5	2.2	2.8	0.3	16.5	1.0	1.6	8.9	5.8	0.0	2.2	1.4	6.0	4.1	5.0	1.5	4.2	16.3	1.0	21.8	1.1	0.9	2.3	0.7	1.1	0.6	1.6	2.5	0.4	4.1	36.4	4.5	5.9	0.8	3.8	2.0	6.3	0.9	5.6	10.1	2.5	1.1	0.9	1.0	0.9	0.4	0.0	2.5	5.9	3.5	2.9	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.0	1.1	0.5	2.2	0.8	0.0	14.6	3.0	2.3	0.0	0.8	0.7	0.0	0.5	1.6	6.5	0.8	0.2	0.0	0.2	1.0	0.6	1.2	0.3	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	1.0	0.0	0.0	0.0	1.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	1.0	1.3	1.0	21.8	1.1	0.6	4.5	0.4
GPR4		ENSG00000177464	"G protein-coupled receptor 4"	P46093	19	45589764-45602208	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 32.0"	"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 14.6;TIME: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014278	Uncertain									"HPA014278: AB_1849300"	"unprognostic (2.49e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (9.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (6.46e-3)"	"unprognostic (1.93e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.49e-3)"	22.6	5.4	6.7	8.4	14.8	1.9	19.7	6.1	12.0	3.3	3.3	3.0	0.3	3.0	5.4	2.7	2.9	4.0	8.6	23.1	8.1	4.5	7.5	4.9	18.6	4.1	8.4	1.3	3.8	6.6	4.5	4.4	10.3	18.6	4.1	2.5	4.5	2.1	3.2	7.7	2.2	3.1	6.8	13.0	4.5	4.4	1.8	8.9	0.0	12.7	2.4	2.2	5.4	32.0	1.1	0.7	1.4	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.7	0.0	0.0	0.2	0.2	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.5	0.3	0.4	0.5	0.4	0.4	0.1	1.1	0.4	0.8	1.4	0.7	0.2	0.7	0.3	0.0	6.7	14.8	6.1	12.0	8.1	4.5	8.4	1.3	18.6	8.9
HOXD12	HOX4H	ENSG00000170178	"Homeobox D12"	P35452	2	176099730-176101193	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7"	"Group enriched"	"Detected in some"	4	"REH: 7.1;SCLC-21H: 2.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	41	"basal ganglia: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059444	Uncertain									"HPA059444: AB_2684020"		"unprognostic (1.00e-1)"	"unprognostic (2.40e-3)"		"unprognostic (1.32e-2)"	"unprognostic (3.53e-2)"		"unprognostic (1.71e-2)"	"unprognostic (1.36e-2)"			"unprognostic (7.11e-2)"		"unprognostic (4.54e-2)"	"unprognostic (7.29e-2)"		"unprognostic (1.44e-2)"	0.1	0.0	0.1	0.1	4.3	0.0	0.1	0.1	0.1	1.4	3.5	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.8	3.4	0.1	0.1	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.2	1.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	1.1	0.5	0.1	7.1	0.0	0.0	0.0	0.1	2.0	0.2	0.6	0.0	0.9	0.9	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HOXD13	"HOX4I, SPD"	ENSG00000128714	"Homeobox D13"	P35453	2	176092891-176095938	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0"	"Group enriched"	"Detected in some"	4	"HAP1: 9.6;HEK 293: 27.6;HL-60: 30.7;NB-4: 18.3;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064064			Approved	Nucleoplasm				Nucleoplasm		"HPA064064: AB_2685186"	"unprognostic (2.04e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (2.52e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.08e-2)"		"unprognostic (4.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.66e-1)"		"unprognostic (1.01e-2)"	"unprognostic (2.82e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.70e-2)"		"unprognostic (9.98e-3)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	14.0	13.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	13.8	8.8	0.1	0.1	19.0	0.6	0.0	0.1	3.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	3.8	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	1.5	0.0	27.6	4.2	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	18.3	0.9	1.5	0.0	0.1	0.0	0.0	0.2	8.0	1.9	1.9	0.0	4.4	0.0	0.0	0.0	1.0	0.0	0.4	2.5	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080738-102139699	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 519.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		94000000	94000000	Cytosol		"CAB002058: "	"prognostic unfavourable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavourable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	50.8	75.3	96.1	46.7	106.8	64.1	118.6	81.3	113.4	51.0	47.3	50.7	43.0	31.0	40.7	55.5	40.9	94.7	61.0	70.9	99.6	113.3	75.6	62.5	51.7	48.1	134.4	58.6	53.4	40.1	94.9	121.6	67.2	143.6	63.2	53.3	23.4	57.0	57.0	65.2	35.6	38.9	51.0	139.7	35.7	41.3	84.6	132.7	53.5	91.5	34.3	59.5	54.2	519.3	30.7	46.9	31.8	29.9	57.7	63.1	21.9	86.3	118.1	75.4	52.0	45.8	38.8	100.2	96.1	46.2	117.9	66.5	71.7	81.2	106.2	90.5	61.8	95.9	216.5	94.0	215.1	80.3	71.3	82.0	67.5	91.5	22.7	122.0	63.3	36.4	40.0	75.3	27.8	65.0	113.2	54.6	106.6	116.8	130.4	56.1	78.4	111.7	125.8	102.5	45.8	68.4	111.7	99.4	71.7	121.5	91.5	53.6	117.6	48.7	46.0	82.5	53.4	122.6	182.5	51.7	161.1	157.1	78.1	75.4	99.4	31.8	19.9	24.0	47.8	29.9	63.1	29.6	40.5	49.0	23.9	30.7	30.1	43.5	13.5	57.7	27.5	46.9	39.2	21.9	96.1	106.8	81.3	102.7	99.6	113.3	134.4	58.6	143.6	132.7
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827735-31830255	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"vagina: 508.1"	"Group enriched"	"Detected in some"	4	"A549: 23.9;Karpas-707: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: "	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	21.9	89.9	25.0	20.3	31.1	5.7	129.4	30.8	23.6	8.4	14.6	17.0	36.6	6.2	19.9	40.5	24.4	13.2	12.6	29.2	25.5	22.5	18.6	28.7	30.8	6.3	61.9	8.5	29.3	36.7	35.1	21.6	6.4	53.8	31.1	8.4	5.6	39.7	48.5	102.8	11.3	11.0	27.9	33.4	10.0	20.5	11.8	55.1	0.9	32.1	14.3	9.7	43.4	508.1	1.1	0.6	1.4	1.3	0.4	0.4	0.3	0.2	23.9	0.1	0.0	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	7.5	1.3	1.0	0.0	0.0	0.0	0.5	7.4	0.0	0.2	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	71.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.1	0.0	0.1	0.0	1.8	0.4	0.0	0.0	0.1	5.0	0.0	0.1	11.6	0.1	0.1	0.0	0.0	0.0	0.5	1.3	1.4	0.1	0.2	0.1	0.2	0.4	0.0	0.6	1.1	0.0	0.0	0.8	0.4	0.7	0.5	0.3	0.3	25.0	31.1	30.8	23.6	25.5	22.5	61.9	8.5	53.8	55.1
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: , HPA061446: AB_2684520"	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favourable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	8.9	11.8	6.4	10.1	4.4	4.5	7.4	4.1	1.7	4.0	4.4	8.6	4.1	0.0	7.5	1.1	2.1	37.3	14.7	5.5	16.7	11.1	4.8	16.2	10.4	1.6	18.5	8.2	4.1	13.7	2.6	9.4	5.1	8.5	5.5	4.9	6.5	5.8	1.6	1.5	9.8	0.0	0.7	0.9	13.5	4.1	11.8	4.3	7.4	12.9	0.6	9.8	3.1	1.4	1.4	0.0	1.7	9.8	10.8	12.4	2.8	5.4	12.6	4.2	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526910	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;vagina: 99.8"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 67.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 67.6"									"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: AB_2681854"	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	6.8	11.9	9.4	10.3	12.4	3.5	43.0	3.5	6.0	1.4	1.9	2.2	1.7	1.9	2.2	1.3	3.2	1.1	9.6	4.5	4.5	9.3	3.1	14.6	13.5	2.1	13.7	1.3	9.3	5.4	0.9	5.4	20.8	5.7	3.3	1.9	1.7	2.9	5.8	1.4	4.4	1.7	4.2	13.2	11.2	3.6	1.4	5.0	1.3	5.8	1.8	2.8	3.1	99.8	0.0	2.5	67.6	9.0	1.6	1.4	2.1	0.5	0.9	0.0	0.2	0.0	0.8	0.7	0.4	0.3	0.1	0.3	0.3	0.5	0.1	1.5	0.1	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.9	0.0	0.0	0.1	2.2	0.1	0.7	0.3	0.0	0.0	0.4	33.3	0.0	0.0	0.1	0.8	0.0	3.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	1.9	0.2	0.4	0.1	0.1	0.3	0.2	2.2	4.5	0.2	0.0	0.8	0.8	1.5	0.8	7.5	2.7	1.4	9.0	0.2	0.0	0.1	0.7	2.5	0.0	0.0	0.3	67.6	1.6	7.3	0.0	0.0	2.1	9.4	12.4	3.5	6.0	4.5	9.3	13.7	1.3	5.7	5.0
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302544-76304295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 565.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 162.0;MCF7: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		57000000	57000000	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	67.6	41.7	23.0	42.9	22.8	7.3	186.2	10.1	21.3	127.6	84.9	10.8	89.2	27.1	126.5	65.9	410.5	57.7	52.2	164.8	21.4	22.5	85.4	26.3	43.3	25.1	25.7	14.3	63.4	34.7	16.6	15.5	106.9	32.8	99.6	12.0	31.1	50.5	101.3	439.2	164.4	24.6	139.7	27.3	17.8	37.6	22.0	23.4	31.9	72.9	207.3	126.8	146.2	565.5	27.8	17.8	4.1	27.9	23.2	36.8	14.4	72.6	54.0	5.8	43.1	35.1	31.1	0.3	30.9	16.3	16.8	21.1	4.8	42.6	0.6	23.9	40.0	66.7	25.3	18.1	5.4	40.5	8.5	3.3	41.7	22.8	18.8	4.9	30.5	38.6	162.0	25.3	3.7	55.4	26.4	74.3	19.2	227.6	8.3	33.6	29.6	47.3	25.7	11.9	59.0	24.9	27.7	0.4	33.1	21.7	88.6	27.6	104.4	34.8	29.9	50.5	75.3	15.7	77.9	5.2	8.6	0.7	36.9	15.2	36.7	4.1	4.5	2.8	18.6	21.1	9.6	27.5	30.6	20.2	11.1	27.8	36.8	31.5	1.7	23.2	27.9	17.8	19.7	14.4	23.0	22.8	10.1	21.3	21.4	22.5	25.7	14.3	32.8	23.4
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		53000000	53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	40.4	49.8	41.8	37.5	28.7	30.0	60.8	42.2	22.3	50.8	37.3	167.0	24.4	123.1	55.1	22.0	41.4	163.6	46.5	72.1	30.2	65.6	87.4	80.6	193.3	27.0	96.8	27.5	33.9	54.0	45.0	79.4	39.8	107.6	48.3	37.3	51.8	60.1	98.0	82.6	104.2	72.3	51.6	88.9	53.4	42.3	54.8	31.0	42.3	45.8	54.1	31.7	57.5	17.7	31.6	43.8	40.6	66.6	27.1	59.6	102.2	37.1	58.5	33.9	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8
KLHL25	"ENC-2, ENC2, FLJ12587"	ENSG00000183655	"Kelch like family member 25"	Q9H0H3	15	85759323-85795030	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 31.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 6.1;NK-cells: 5.1;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 36.7;hippocampal formation: 25.8"	HPA023450	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023450: AB_1852583"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.66e-2)"	10.6	4.2	5.2	6.8	12.1	1.5	12.7	3.9	21.5	4.7	4.8	7.5	7.7	9.9	7.9	7.2	8.2	6.2	5.2	4.2	5.7	5.9	4.3	18.3	4.8	4.0	5.3	5.8	4.4	3.6	4.4	4.6	2.8	5.4	5.7	2.9	3.8	6.2	7.6	7.8	9.7	7.0	6.2	3.0	2.6	7.5	16.3	4.3	3.7	4.7	2.5	3.9	4.1	31.5	0.6	1.2	0.5	6.1	5.1	3.5	1.0	2.3	7.0	10.3	5.0	2.1	1.1	5.3	2.9	1.4	4.2	3.2	9.4	3.9	1.4	1.5	2.4	5.8	11.1	5.6	0.9	1.4	5.1	0.4	3.0	7.1	2.4	0.4	1.8	2.1	1.9	4.0	1.4	2.2	0.6	1.3	1.7	4.3	3.6	2.2	9.3	3.7	7.4	6.2	2.4	1.5	4.9	14.4	10.0	4.3	5.0	1.8	9.1	0.6	1.9	4.4	8.1	2.8	5.3	1.5	3.0	1.5	1.9	2.6	2.4	0.0	0.2	0.5	2.0	2.3	1.1	0.1	2.1	1.5	0.5	0.6	3.5	2.2	0.0	5.1	6.1	1.2	1.8	1.0	5.2	12.1	3.9	11.1	5.7	5.9	5.3	5.8	5.4	4.3
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favourable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LCE3D	"LEP16, SPRL6A, SPRL6B"	ENSG00000163202	"Late cornified envelope 3D"	Q9BYE3	1	152579381-152580504	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5"	"Group enriched"	"Detected in some"	6	"hTCEpi: 8.5;hTERT-HME1: 7.9"	"Group enriched"	"Detected in many"	9	"head and neck cancer: 126.9;melanoma: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.34e-1)"				"unprognostic (1.09e-1)"			"unprognostic (2.87e-1)"									0.3	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	53.2	0.1	0.1	0.1	0.0	3.7	0.1	7.8	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	8.5	0.1	0.1	17.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.9	0.1	96.6	48.6	0.1	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	7.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LCE3E	LEP17	ENSG00000185966	"Late cornified envelope 3E"	Q5T5B0	1	152565654-152566772	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 35.6;lymphoid tissue: 21.3;tongue: 38.9;vagina: 19.8"	"Cell line enriched"	"Detected in single"	6	"hTCEpi: 4.9"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 40.7;melanoma: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.33e-1)"				"unprognostic (7.76e-2)"			"unprognostic (2.51e-1)"									0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	35.6	0.1	0.1	0.1	0.0	1.9	0.1	9.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	3.5	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	38.9	21.3	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MAP3K11	"MEKK11, MLK3, PTK1, SPRK"	ENSG00000173327	"Mitogen-activated protein kinase kinase kinase 11"	Q16584	11	65597755-65615382	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 75.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010165	Approved		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"CAB010165: AB_631936"	"unprognostic (8.36e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.27e-3)"	23.2	10.8	11.4	23.7	21.2	14.2	27.4	7.9	13.8	8.6	15.8	29.8	6.1	31.9	11.0	8.1	14.7	11.6	12.0	11.6	13.3	8.1	16.1	31.2	21.1	14.4	30.9	8.2	8.4	12.5	8.3	10.3	14.7	16.7	13.4	8.2	15.4	13.5	9.5	11.9	13.7	31.9	8.6	17.7	28.8	16.9	8.6	19.0	8.9	13.6	7.6	12.7	8.9	75.8	2.3	7.6	13.8	12.0	1.8	3.5	5.6	16.5	14.6	7.9	8.4	2.5	3.2	8.1	6.4	4.5	7.7	5.3	14.6	16.0	6.2	23.7	5.0	14.4	4.7	6.9	2.8	13.6	6.0	17.5	10.0	17.4	7.0	10.0	26.5	5.0	6.7	5.7	5.2	21.5	7.5	12.5	4.0	20.4	11.7	18.9	8.6	18.7	19.5	5.1	12.6	7.2	14.3	7.1	8.0	7.5	21.8	37.5	17.4	16.3	23.9	11.8	12.8	17.2	11.3	8.0	9.0	5.5	13.8	11.6	27.3	4.3	7.7	9.2	2.4	12.0	2.4	2.0	2.6	3.5	7.6	2.3	2.0	1.5	13.8	1.8	11.7	2.3	1.4	5.6	11.4	21.2	7.9	13.8	13.3	8.1	30.9	8.2	16.7	19.0
MICB	PERB11.2	ENSG00000204516	"MHC class I polypeptide-related sequence B"	Q29980	6	31494881-31511124	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 26.5"	"Cell line enhanced"	"Detected in many"		"U-266/70: 11.4;U-266/84: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA064618			Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA064618: AB_2685301"	"unprognostic (3.63e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavourable (7.04e-5)"	"unprognostic (2.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (4.94e-9)"	"unprognostic (1.91e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.21e-2)"	3.3	1.2	0.8	9.1	0.8	6.1	3.5	3.0	1.0	1.8	1.6	0.9	0.0	1.0	2.1	1.3	2.1	1.1	1.7	2.2	1.0	0.6	2.9	1.3	6.9	7.8	1.2	0.8	1.3	2.9	0.2	0.6	0.8	1.2	1.1	1.9	1.1	1.9	0.7	0.8	1.0	5.0	1.7	1.5	11.7	1.4	2.3	1.1	8.1	2.4	0.7	8.1	3.2	26.5	2.2	2.1	4.1	4.8	1.9	4.4	1.9	2.4	0.8	0.0	0.0	1.5	2.4	0.0	1.7	1.6	2.2	2.8	0.0	0.3	2.7	6.1	3.1	0.6	0.7	2.8	0.8	2.4	2.6	3.2	0.4	1.1	0.5	1.0	2.6	3.1	0.6	3.7	2.2	1.4	3.3	5.8	2.6	0.0	0.9	4.2	0.3	0.4	3.3	0.0	5.8	2.5	0.1	0.0	0.0	1.1	0.0	0.5	1.5	1.1	1.4	1.7	0.0	1.4	0.0	11.4	26.1	6.1	0.4	8.6	3.6	4.1	3.1	4.0	2.9	3.6	3.6	2.2	2.9	3.9	2.1	2.0	1.6	3.1	3.1	1.9	4.8	1.3	4.4	1.9	0.8	0.8	3.0	1.0	1.0	0.6	1.2	0.8	1.2	1.1
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 50.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8.0	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3.0	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10.0	6.0	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.1	0.1	0.1	3.1	6.7	0.1	8.4	7.3	8.0	11.8	7.0	13.1	0.1	9.7	7.1	10.5	2.2	12.2	3.0	4.1	0.3	9.1	9.0	7.9	2.3	5.9	9.5	4.4	1.2	8.5	3.0	19.2	1.3	1.3	6.2	10.8	3.4	11.9	1.0	14.9	6.6	0.9	11.7	11.3	4.8	0.5	0.4	6.7	4.4	3.7	3.2	6.3	20.9	4.0	2.4	3.6	5.7	5.6	19.1	1.6	7.2	21.0	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6.0	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955734	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 12.6;vagina: 10.8"	"Group enriched"	"Detected in some"	5	"HaCaT: 19.1;PC-3: 7.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.5	0.1	0.0	0.8	0.0	1.3	0.4	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	12.6	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.1	0.1	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.1	1.9	0.0	1.4	0.0	0.0	0.1	4.6	10.8	1.0	0.7	2.7	0.5	1.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	7.2	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	2.7	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.6	1.3	0.4	1.0	0.5	0.7	0.8	0.3	1.0	0.6	1.1	1.9	1.9	0.3	0.7	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavourable (9.01e-4)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavourable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	17.3	4.5	13.0	25.3	40.2	30.9	10.9	51.0	46.2	19.7	47.4	7.4	13.5	5.9	19.5	50.4	19.7	8.2	18.6	43.3	7.5	3.1	5.0	4.3	8.8	16.7	9.2	3.5	18.7	10.9	16.8	22.3	9.3	7.8	3.1	17.0	4.6	3.6	8.9	4.6	19.8	3.4	8.7	10.6	11.1	7.5	1.2	7.3	10.4	30.8	12.1	4.7	8.7	8.8	24.2	10.0	6.7	11.8	17.7	6.4	2.8	43.4	13.5	11.7	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 21.3;skin 1: 39.1;vagina: 10.9"	"Group enriched"	"Detected in some"	15	"HaCaT: 8.6;HDLM-2: 3.5;hTCEpi: 3.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.5"					"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0			0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.9	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		3.8	0.0	10.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0										
PGLYRP4	"PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67"	ENSG00000163218	"Peptidoglycan recognition protein 4"	Q96LB8	1	153330120-153348840	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;HDLM-2: 5.2;hTCEpi: 1.7;Karpas-707: 4.3"	"Group enriched"	"Detected in some"	9	"cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB025879			Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"		"CAB025879: "	"unprognostic (2.76e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.34e-2)"		"unprognostic (3.61e-3)"		"unprognostic (1.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-2)"		"unprognostic (2.15e-1)"	"unprognostic (1.81e-1)"		"unprognostic (1.88e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	8.1	0.0	0.0	0.0	0.1	2.0	0.0	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.2	0.2	0.0	1.5	0.0	0.1	19.5	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	13.7	6.5	0.0	8.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	5.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089121-123194266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;HEK 293: 9.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA030324	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	1.3	0.3	0.3	0.6	0.3	0.0	1.4	0.4	0.5	1.6	6.7	0.4	0.3	0.4	1.8	0.6	1.2	0.6	19.7	0.9	0.4	0.3	0.6	0.3	10.6	0.0	0.5	0.4	3.8	0.5	0.3	0.5	8.1	3.6	14.1	1.9	0.0	0.3	0.8	0.2	0.4	1.0	29.7	0.8	0.1	1.1	0.5	0.0	0.0	1.4	0.2	0.6	18.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.6	0.9	6.8	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.5	0.0	1.4	0.0	0.0	0.3	9.6	2.0	0.9	0.0	2.0	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.4	0.1	1.5	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.4	0.3	0.5	0.4	3.6	0.0
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475828-203491352	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 183.7"	"Group enriched"	"Detected in some"	9	"ASC diff: 18.5;BJ: 7.5;fHDF/TERT166: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	280000	280000				"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.02e-4)"	46.7	16.0	6.3	7.7	5.8	1.1	52.3	3.6	5.0	57.4	35.7	3.7	16.8	5.0	45.3	17.8	46.2	29.5	27.4	58.6	7.0	1.8	8.1	7.3	49.9	5.2	6.4	9.5	62.3	6.6	1.8	7.3	8.3	8.6	48.3	6.6	64.6	10.4	52.5	24.5	16.4	17.0	61.8	7.7	22.6	13.5	23.4	3.3	0.0	25.1	16.1	11.5	98.7	183.7	1.0	1.0	4.0	1.2	1.1	0.8	0.6	0.2	0.2	0.5	0.2	18.5	0.5	0.5	7.5	1.0	0.2	0.2	0.0	0.2	1.1	0.7	11.4	0.7	0.2	0.3	0.3	0.1	0.2	0.4	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.5	1.3	0.1	0.2	0.5	0.5	0.1	0.4	0.2	0.5	0.0	0.3	1.1	0.3	0.2	0.2	0.8	0.3	0.2	0.6	0.5	0.3	0.3	0.1	0.3	0.4	1.2	0.1	0.2	0.5	4.0	1.2	1.7	0.7	1.0	0.8	0.6	0.7	0.5	0.4	1.0	0.7	0.6	2.7	1.1	1.1	1.0	0.6	0.6	6.3	5.8	3.6	5.0	7.0	1.8	6.4	9.5	8.6	3.3
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol		580000	580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavourable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favourable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	79.9	69.8	56.6	33.7	41.7	37.9	86.3	52.4	40.1	67.5	50.5	59.1	84.4	88.7	79.7	44.7	51.6	106.1	68.5	85.6	65.1	70.6	69.2	44.1	68.2	30.6	82.2	50.3	27.4	50.1	51.0	61.9	69.4	111.0	85.0	65.9	49.9	81.6	78.1	96.7	81.5	71.4	53.4	119.0	59.4	62.6	73.4	42.9	53.5	77.2	45.4	88.9	69.1	41.6	40.6	47.2	48.7	72.4	35.8	98.6	71.3	44.2	67.9	73.0	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1
RARRES1	"LXNL, TIG1"	ENSG00000118849	"Retinoic acid receptor responder 1"	P49788	3	158696892-158732696	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 105.0;vagina: 111.3"	"Cell line enriched"	"Detected in some"	9	"CAPAN-2: 158.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003892	Uncertain		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA003892: AB_1856079"	"unprognostic (5.76e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (7.09e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.47e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.88e-6)"	"unprognostic (3.49e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.15e-1)"	49.4	6.1	0.4	26.5	0.5	0.0	54.5	0.3	0.4	18.5	29.9	0.6	10.0	2.1	6.8	24.2	11.5	40.6	8.3	105.0	0.6	0.3	26.8	2.7	13.4	13.3	0.5	0.5	75.5	3.9	0.0	19.7	1.6	2.0	46.2	15.7	19.4	49.0	17.9	10.5	3.3	9.3	20.7	2.4	3.2	6.6	19.0	0.2	1.0	31.5	1.7	5.9	39.6	111.3	1.0	1.2	0.0	0.9	0.2	0.7	0.1	2.4	0.8	0.0	0.1	0.5	1.5	0.0	0.2	0.7	0.1	0.1	0.1	158.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	17.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.2	2.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.4	1.0	0.7	0.3	0.0	0.2	0.9	1.2	0.3	0.1	0.4	0.5	0.3	0.4	0.6	0.3	0.5	0.5	2.0	0.2
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496613	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.8;hTCEpi: 4.4;RT4: 4.4;SK-MEL-30: 2.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"olfactory region: 10.4"	"Low region specificity"	"Detected in many"			"HPA041874, HPA043317"	Enhanced									"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.0	0.5	60.6	0.2	0.0	0.0	0.2	4.4	0.2	304.0	0.3	0.3	0.3	0.2	0.0	8.6	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.1	37.3	0.3	0.2	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	115.4	185.9	0.5	91.8	0.6	0.3	0.0	0.2	0.0	0.6	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.6	1.6	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	4.4	0.3	0.3	0.8	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.6	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.0
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.6;vagina: 6.6"	"Group enriched"	"Detected in some"	30	"HAP1: 6.7;HEK 293: 3.9;NTERA-2: 13.6"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"olfactory region: 15.4"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain									"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.7	0.7	7.3	0.7	7.6	0.7	0.7	0.3	11.6	0.9	0.7	8.3	0.0	0.7	0.7	2.1	0.7	0.7	0.7	1.2	7.1	5.4	4.4	0.7	0.7	0.7	5.7	3.3	0.7	0.7	0.7	1.1	0.8	6.8	6.0	0.7	0.2	0.7	1.2	0.7	0.7	0.7	0.7	8.8	0.7	0.7	2.4	4.6	0.0	0.9	0.0	0.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.6	0.3	6.6	7.1	5.4	5.7	3.3	6.8	4.6
SERPINB12	YUKOPIN	ENSG00000166634	"Serpin family B member 12"	Q96P63	18	63556160-63567011	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 9.3;skin 1: 38.8;vagina: 16.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;CAPAN-2: 1.0;hTCEpi: 2.4;U-266/70: 2.9"	"Group enriched"	"Detected in some"	14	"cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									8500000	8500000					"unprognostic (7.35e-2)"				"prognostic favourable (1.76e-4)"		"unprognostic (1.57e-1)"	"unprognostic (2.00e-1)"						"unprognostic (8.10e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	9.3	0.0			0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.4	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.3			0.0		1.4	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 165.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 117.6;HHSteC: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	730000	730000	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	38.2	20.1	10.5	29.3	10.9	1.0	54.1	5.7	8.4	39.4	16.9	6.0	10.3	6.4	32.7	16.8	17.8	23.6	21.4	29.6	11.8	7.0	18.5	11.5	35.7	13.5	17.1	2.7	48.3	13.9	5.9	11.0	69.9	23.2	26.2	11.0	13.8	7.7	16.7	9.5	12.3	9.4	57.8	12.9	14.3	14.2	12.5	13.0	7.4	36.1	8.7	8.2	38.7	165.4	1.3	5.5	5.0	1.6	7.1	7.4	2.4	5.4	18.3	34.5	71.0	53.5	49.4	15.7	50.4	34.3	38.0	48.5	97.4	28.5	0.0	45.7	117.6	32.7	23.6	15.7	18.5	2.2	4.5	3.9	18.1	19.5	104.4	0.1	0.7	58.8	16.2	36.3	12.2	51.9	8.3	1.7	17.7	42.7	0.1	6.9	30.6	4.9	2.7	19.1	4.4	9.2	10.4	0.8	11.4	31.5	5.9	9.5	14.0	6.7	27.3	39.2	32.7	26.7	12.2	2.2	2.2	0.5	16.9	0.0	52.5	5.0	1.6	0.1	7.4	1.5	6.7	1.2	5.1	5.3	5.5	1.3	5.7	4.6	0.3	7.1	0.2	4.7	4.2	2.4	10.5	10.9	5.7	8.4	11.8	7.0	17.1	2.7	23.2	13.0
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell line enriched"	"Detected in single"	50	"RT4: 41.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Group enriched"	"Detected in some"	4	"basal ganglia: 0.8;olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: "	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Group enriched"	"Detected in some"	84	"HeLa: 239.2;SiHa: 114.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011039	Uncertain				"Secreted - unknown location"					"HPA011039: AB_2668412"		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favourable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	239.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor, Kazal type 7 (putative)"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 161.8;tongue: 124.0;vagina: 79.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.9;HeLa: 2.1;hTCEpi: 3.9;PC-3: 3.1;SiHa: 1.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted - unknown location"	90000	90000			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	39.1	0.1	0.0	0.0	0.1	2.8	0.1	161.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	16.9	0.1	0.2	1.1	0.1	0.1	0.0	0.1	1.3	0.1	0.0	0.6	0.1	124.0	30.6	0.2	79.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 168.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		3700000	3700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.23e-4)"	"prognostic unfavourable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	27.3	49.7	32.2	32.0	40.5	25.8	41.5	45.3	41.9	28.3	25.5	29.2	20.6	19.2	30.1	25.2	31.5	36.2	21.6	34.4	32.2	42.8	24.7	27.8	25.4	31.9	47.7	22.5	34.1	24.1	39.1	38.3	37.0	40.7	30.1	28.5	20.3	22.6	29.5	51.9	27.6	20.7	33.2	39.7	26.5	24.4	56.4	49.0	29.8	46.1	23.4	41.2	26.0	168.2	32.2	26.8	20.9	39.6	39.5	35.9	39.5	49.0	76.6	48.4	40.3	27.0	18.0	43.6	44.6	24.0	64.8	37.8	56.1	42.1	58.7	52.5	35.3	52.1	121.3	44.7	71.3	46.1	49.5	82.7	51.5	51.5	23.5	43.6	52.3	18.2	28.1	53.6	40.5	45.6	81.6	33.8	37.2	71.8	65.6	59.5	58.3	64.8	64.5	46.1	59.5	45.2	43.5	39.5	35.1	50.9	53.9	41.4	57.2	30.2	40.9	41.2	51.0	53.8	60.0	30.8	66.5	62.0	53.4	43.9	59.3	19.0	25.3	20.9	35.9	36.2	35.7	32.2	27.2	32.0	26.8	26.0	30.5	33.8	7.7	39.5	39.6	22.2	24.0	39.5	32.2	40.5	45.3	41.9	32.2	42.8	47.7	22.5	40.7	49.0
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Group enriched"	"Detected in some"	19	"HHSteC: 37.1;HSkMC: 16.8;hTCEpi: 14.0;HUVEC TERT2: 10.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"											"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"		"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.1	0.0	0.0	16.8	14.0	0.0	0.4	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1
TBX18		ENSG00000112837	"T-box 18"	O95935	6	84687351-84764519	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 23.3"	"Cell line enhanced"	"Detected in many"		"A549: 26.1;ASC diff: 19.0;ASC TERT1: 19.8;RH-30: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	14.5	4.9	1.7	2.1	4.0	0.3	16.1	1.8	3.6	4.4	1.9	4.1	0.5	0.5	2.4	2.1	7.3	2.7	3.6	9.9	3.4	1.8	1.0	0.8	0.7	3.9	6.3	5.5	5.0	1.4	1.3	2.6	4.1	5.0	4.9	1.3	8.9	3.9	2.9	2.5	8.0	2.7	11.1	4.0	0.3	1.0	2.5	1.8	0.0	2.8	2.0	3.0	7.6	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	19.0	19.8	0.0	10.7	5.3	8.2	7.8	0.1	0.0	0.0	0.0	4.4	1.4	0.0	6.3	6.7	0.0	10.6	0.0	0.0	0.0	2.4	0.0	10.8	8.1	0.6	5.6	12.1	9.4	13.5	0.1	5.6	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.1	0.0	0.1	0.5	0.0	0.4	4.2	0.0	14.0	8.2	0.0	2.3	8.2	0.0	0.1	0.0	0.0	5.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.0	1.8	3.6	3.4	1.8	6.3	5.5	5.0	1.8
THEGL		ENSG00000249693	"Theg spermatid protein like"	P0DJG4	4	56530609-56603507	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.9;vagina: 10.7"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.7;HSkMC: 3.6;hTEC/SVTERT24-B: 2.2;K-562: 2.9;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA068093	Uncertain									"HPA068093: AB_2685951"	"unprognostic (4.33e-2)"	"unprognostic (2.88e-3)"		"unprognostic (7.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.69e-2)"		"unprognostic (3.26e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.41e-2)"	0.1	0.2	0.6	0.1	0.5	0.8	1.9	0.1	1.1	1.7	0.7	0.6	1.0	0.1	0.4	1.3	0.2	0.4	0.8	0.1	0.2	0.4	0.1	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.0	0.3	0.0	0.8	0.7	0.1	0.2	0.2	0.5	0.1	1.2	0.2	1.8	0.2	0.1	0.3	8.9	0.4	0.0	0.1	0.0	0.1	3.0	10.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.3	3.6	0.0	2.2	0.0	0.4	2.9	0.0	0.8	0.0	0.8	0.0	0.2	0.4	0.4	0.4	0.0	0.0	0.0	0.1	1.9	0.8	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.2	0.8	0.1	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.1	1.1	0.2	0.4	0.2	0.3	0.8	0.4
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447449-68497604	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6"	"Group enriched"	"Detected in some"	6	"HaCaT: 5.8;HBEC3-KT: 2.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051062	Enhanced				"Intracellular and membrane"					"HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavourable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.9	0.0	0.0	1.2	0.0	1.1	10.5	103.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.6	0.5	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	40.5	39.1	2.6	36.6	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	5.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075617	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;urinary bladder: 20.1;vagina: 12.1"	"Cell line enriched"	"Detected in some"	6	"HHSteC: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favourable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.3	0.2	0.2	9.1	0.2	0.0	0.2	0.2	0.4	0.4	16.8	0.3	0.0	4.8	0.2	0.3	2.2	0.2	5.7	0.3	0.2	0.2	0.2	0.2	0.3	0.8	0.3	0.0	0.4	0.2	0.0	0.2	0.3	0.1	4.7	7.5	0.0	0.2	0.0	0.2	0.2	20.8	3.8	0.2	0.4	7.9	0.4	0.0	0.6	0.2	0.3	1.4	20.1	12.1	0.5	0.6	0.1	1.1	0.3	2.6	0.2	0.0	2.4	0.7	0.0	0.0	0.1	0.0	0.3	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	1.3	0.1	0.0	0.5	0.0	24.1	0.0	0.2	1.6	0.0	1.1	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	2.3	0.0	0.3	0.0	0.1	3.8	1.1	0.0	0.3	0.2	0.0	1.8	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.5	2.6	0.0	0.5	0.0	0.4	0.1	0.3	1.1	0.6	1.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.0	0.1	0.0
UCN2	"SRP, UCN-II, UCNI, URP"	ENSG00000145040	"Urocortin 2"	Q96RP3	3	48561727-48563773	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skin 1: 18.6;vagina: 6.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 15.3;hTEC/SVTERT24-B: 12.1;SiHa: 10.5;U-251 MG: 11.2;WM-115: 31.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA066841	Uncertain				"Secreted to blood"					"HPA066841: AB_2685735"	"unprognostic (7.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-14)"	"unprognostic (4.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-2)"	1.7	0.0	0.3	0.5	0.9	0.1	0.6	0.3	0.3	2.0	0.3	0.3	0.3	0.1	1.8	1.1	3.7	0.1	0.6	0.3	0.3	0.5	0.9	0.3	0.3	0.3	1.6	0.3	0.3	0.3	0.0	0.3	0.3	0.9	3.3	0.1	0.3	1.6	0.7	0.3	18.6	0.3	0.4	0.3	0.5	0.1	1.1	0.3	0.3	0.3	0.3	0.3	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	1.0	0.6	1.4	5.3	6.7	3.3	2.5	0.0	0.0	0.0	0.2	1.2	1.0	0.0	6.4	1.8	4.9	0.1	0.1	8.7	0.7	1.1	0.0	0.3	0.7	15.3	12.1	2.4	0.0	0.0	0.1	0.5	0.0	0.0	0.9	0.4	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	10.5	0.0	7.9	0.1	0.2	0.0	1.5	1.0	0.1	11.2	0.0	0.1	0.0	5.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.3	0.3	0.3	0.5	1.6	0.3	0.9	0.3
